PPARα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene

EMBO Journal

Volumn 15, Issue 19, 1996, Pages 5336-5348

  Schoonjans, Kristina ^a   Peinado Onsurbe, Julia ^b   Lefebvre, Anne Marie ^a   Heyman, Richard A ^c   Briggs, Michael ^c   Deeb, Samir ^d   Staels, Bart ^a   Auwerx, Johan ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b UNIVERSITY OF BARCELONA   (Spain)

^c LIGAND PHARMACEUTICALS INC   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Atherosclerosis; Gene expression; Lipoproteins; Nuclear receptors; Peroxisomes

Indexed keywords

CELL NUCLEUS RECEPTOR; FENOFIBRIC ACID; LIPOPROTEIN; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CELL RECEPTOR; DNA; DRUG DERIVATIVE; FENOFIBRATE; MESSENGER RNA; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; ROSIGLITAZONE; THIAZOLE DERIVATIVE; TRANSCRIPTION FACTOR;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; GENE EXPRESSION; IN VITRO STUDY; LIVER CELL; NONHUMAN; PEROXISOME; PHENOTYPE; PRIORITY JOURNAL; PROADIPOCYTE; PROMOTER REGION; RAT; TISSUE DISTRIBUTION; ANIMAL; ANTIBODY SPECIFICITY; C57BL MOUSE; CELL LINE; CELL STRAIN 3T3; CHEMISTRY; CYTOLOGY; DIMERIZATION; DRUG EFFECT; GENETICS; HEART MUSCLE; HUMAN; LIVER; METABOLISM; MOUSE; SPRAGUE DAWLEY RAT; TRANSACTIVATION;

3T3 CELLS; ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; ANTILIPEMIC AGENTS; CELL LINE; DIMERIZATION; DNA; HUMANS; HYPOGLYCEMIC AGENTS; LIPOPROTEIN LIPASE; LIVER; MICE; MICE, INBRED C57BL; MYOCARDIUM; ORGAN SPECIFICITY; PROCETOFEN; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RNA, MESSENGER; THIAZOLES; THIAZOLIDINEDIONES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 0029791412     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb00918.x     Document Type: Article

References (83)

1. Aalto-Setälä, K. et al. (1992) Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. J. Clin. Invest., 90, 1889-1900.
2. Alvarez, K. et al. (1994) An upstream region of the enoyl-coenzyme A hydratase 3-hydroxyacyl-coenzyme A dehydrogenase gene directs luciferase expression in liver in response to peroxisome proliferators in transgenic mice. Cancer Res., 54, 2303-2306.
3. Amri, E.-Z., Bertrand, B., Ailhaud, G. and Grimaldi, P. (1991) Regulation of adipose cell differentiation. I. Fatty acids are inducers of the aP2 gene expression. J. Lipid Res., 32, 1449-1456.
4. Amri, E.-Z., Bonino, F., Ailhaud, G., Abumrad, N.A. and Grimaldi, P.A. (1995) Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. J Biol. Chem., 270, 2367-2371.
5. Aperlo, C., Pognonec, P., Saladin, R., Auwerx, J. and Boulukos, K. (1995) Isolation and characterization of the hamster peroxisomal proliferator activated receptor hPPARγ, a member of the nuclear hormone receptor superfamily. Gene, 162, 297-302.
6. Auwerx, J., Deeb, S., Brunzell, J.D., Wolfbauer, G. and Chait, A. (1989) Lipoprotein lipase gene expression in THP-1 cells. Biochemistry, 28, 4563-4567.
7. Auwerx, J., Leroy, P. and Schoonjans, K. (1992) Lipoprotein lipase: recent contributions from molecular biology. Crit. Rev. Clin. Lab. Sci., 29, 243-268.
8. Bardot, O., Aldridge, T.C., Latruffe, N. and Green, S. (1993) PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene. Biochem. Biophys. Res. Commun., 192, 37-45.
9. Batchvarova, N., Wang, X.-Z. and Ron, D. (1995) Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd153). EMBO J., 14, 4654-4661.
10. Beck, F., Plummer, S., Senior, P.V., Byrne, S., Green, S. and Brammar, W.J. (1992) The ontogeny of peroxisome-proliferator-activated receptor gene expression in the mouse and rat. Proc. R. Soc. Lond. Biol., 247, 83-87.
11. Braissant, O., Foufelle, F., Scotto, C., Dauca, M. and Wahli, W. (1995) Differential expression of peroxisome proliferator-activated receptors: tissue distribution of PPARα, β and γ in the adult rat. Endocrinology, 137, 354-366.
12. Brun, R.P., Tontonoz, P., Forman, B.M., Ellis, R., Chen, J., Evans, R.M. and Spiegelman, B.M. (1996) Differential activation of adipogenesis by multiple PPAR isoforms. Genes Dev., 10, 974-984.
13. Buchanan, T.A., Meehan, W.P., Jeng, Y.Y., Yang, D., Chan, T.M., Nadler, J.L., Scott, S., Rude, R.K. and Hsueh, W.A. (1995) Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect. J. Clin. Invest., 96, 354-360.
14. Chawla, A. and Lazar, M.A. (1994) Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival. Proc. Natl Acad. Sci. USA, 91, 1786-1790.
15. de Silva, H.V., Lauer, S.J., Wang, J., Simonet, W.S., Weisgraber, K.H., Mahley, R.W. and Taylor, J.M. (1994) Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E. J. Biol. Chem., 269, 2324-2335.
16. De Vos, P. et al. (1996) Thiazolidinediones repress ob gene expression via activation of PPARγ. J. Clin. Invest., in press.
17. Deeb, S. and Peng, R. (1989) Structure of the human lipoprotein lipase gene. Biochemistry, 28, 4131-4135.
18. Distel, R.J., Robinson, G.S. and Spiegelman, B.M. (1992) Fatty acid regulation of gene expression: transcriptional and post-transcriptional mechanisms. J. Biol. Chem., 267, 5937-5941.
19. Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G. and Wahli, W. (1992) Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell, 68, 879-887.
20. Dreyer, C., Keller, H., Mahfoudi, A., Laudet, V., Krey, G. and Wahli, W. (1993) Positive regulation of peroxisomal β-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR). Biol. Cell, 77, 67-77.
21. Flier, J.S. (1995) Syndromes of insulin resistance and mutant insulin. In De Groot, L.J. (ed.), Endocrinology. W.B.Saunders, Philadelphia, PA, pp. 1592-1604.
22. Forman, B.M., Tontonoz, P., Chen, J., Brun, R.P., Spiegelman, B.M. and Evans, R.M. (1995) 15-Deoxy-Δ12,14 prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell, 83, 803-812.
23. Fried, M.G. and Crothers, D.M. (1983) CAP and RNA polymerase interactions with the lac promoter: binding stoichiometry and long range effects. Nucleic Acids Res., 11, 141-158.
24. Gaillard, D., Negrel, R., Lagarde, M. and Ailhaud, G. (1989) Requirement and role of arachidonic acid in the differentiation of pre-adipose cells. Biochem. J., 257, 389-397.
25. Gnasso, A., Lehner, B., Haberbosch, W., Leiss, O., von Bergman, K. and Augustin, J. (1986) Effect of gemfibrozil on lipids, apoproteins, and postheparin lipolytic activities in normolipidemic subjects. Metabolism, 35, 387-394.
26. Gottlicher, M., Widmark, E., Li, Q. and Gustafsson, J.A. (1992) Fatty acids activate chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl Acad. Sci. USA, 89, 4653-4657.
27. Grundy, S.M. and Denke, M.A. (1990) Dietary influences on serum lipids and lipoproteins. J. Lipid Res., 31, 1149-1172.
28. Gulick, T., Cresci, S., Caira, T., Moore, D.D. and Kelly, D.P. (1994) The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc. Natl Acad. Sci. USA, 91, 11012-11016.
29. Heller, F. and Harvengt, C. (1983) Effects of clofibrate, bezafibrate, fenofibrate, and probucol on plasma lipolytic enzymes in normolipidaemic subjects. Eur. J. Clin. Pharmacol., 23, 57-63.
30. Hertz, R., Bishara-Shieban, J. and Bar-Tana, J. (1995) Mode of action of peroxisome proliferators as hypolipidemic drugs, suppression of apolipoprotein C-III. J. Biol. Chem., 270, 13470-13475.
31. Hiragun, A., Sato, M. and Mitsui, H. (1988) Preadipocyte differentiation in vitro: identification of a highly active adipogenic agent. J. Cell. Physiol., 134, 124-130.
32. Hu, E., Tontonoz, P. and Spiegelman, B.M. (1995) Transdifferentiation of myoblasts by the adipogenic transcription factors PPARgamma and C/EBPalpha. Proc. Natl Acad. Sci. USA, 92, 9856-9860.
33. Hua, X., Enerback, S., Hudson, J., Youkhana, K. and Gimble, J.M. (1991) Cloning and characterization of the murine lipoprotein lipase-encoding gene: structural and functional analysis. Gene, 107, 247-258.
34. Ikeda, H., Taketomi, S., Sugiyama, Y., Shimura, Y., Sohda, T., Meguro, K. and Fujita, T. (1990) Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistent animals. Drug Res., 40, 156-162.
35. Isseman, I. and Green, S. (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature, 347, 645-650.
36. Keller, H., Dreyer, C., Medin, J., Mahfoudi, A., Ozato, K. and Wahli, W. (1993) Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc. Natl Acad. Sci. USA, 90, 2160-2164.
37. Kletzien, R.F., Clarke, S.D. and Ulrich, R.G. (1992) Enhancement of adipocyte differentiation by an insulin sensitizing agent. Mol. Pharmacol., 41, 393-398.
38. Kliewer, S.A., Forman, B.M., Blumberg, B., Ong, E.S., Borgmeyer, U., Mangelsdorf, D.J., Umesono, K. and Evans, R.M. (1994) Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl Acad. Sci. USA, 91, 7355-7359.
39. Kliewer, S.A., Lenhard, J.M., Willson, T.M., Patel, I., Morris, D.C. and Lehman, J.M. (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell, 83, 813-819.
40. Lehmann, J.M., Moore, L.B., Smith-Oliver, T.A., Wilkison, W.O., Willson, T.M. and Kliewer, S.A. (1995) An antidiabetic thiazolidinedione is a high affinity ligand for Peroxisome Proliferator-Activated Receptor γ (PPARy). J. Biol. Chem., 270, 12953-12956.
41. Leid, M. et al. (1992) Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell, 68, 377-395.
42. Levy, E., Thibault, L., Turgeon, J., Roy, C.C., Gurbindo, C., Lepage, G., Godard, M., Rivard, G.E. and Seidman, E. (1993) Beneficial effect of fish-oil supplements on lipids, lipoproteins, and lipoprotein lipase in patients with glycogen storage disease type I. Am. J. Clin. Nutr., 57, 922-929.
43. Lock, E.A., Mitchell, A.M. and Elcombe, C.R. (1989) Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annu. Rev. Pharmacol. Toxicol., 29, 145-163.
44. Luckow, B. and Schütz, G. (1987) CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res., 15, 5490.
45. Maegawa, H., Ide, R., Hasegawa, M., Ugi, S., Egawa, K., Iwanishi, M., Kikkawa, R., Shigeta, Y. and Kashigawa, .A. (1995) Thiazolidine derivatives ameliorate high glucose-induced insulin resistance via the normalization of protein-tyrosine phosphatase activities. J. Biol. Chem., 270, 7724-7730.
46. Marcus, S.L., Miyata, K.S., Zhang, B., Subramani, S., Rachubinski, R.A. and Capone, J.P. (1993) Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive element of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression. Proc. Natl Acad. Sci. USA, 90, 5723-5727.
47. Martin, L.F., Hunter, S., Lauve, R.M. and O'Leary, J.P. (1995) Severe obesity: expensive to society, frustrating to treat, but important to confront. Southern Med. J., 88, 895-902.
48. Masiakowski, P., Breathnach, R., Bloch, J., Gannon, F., Krust, A., and Chambon, P. (1982) Cloning of cDNA sequences of hormone-regulated genes from MCF-7 human breast cancer cell line. Nucleic Acids Res., 10, 7895-7903.
49. Moller, D.E. and Flier, J.S. (1991) Insulin resistance-mechanisms, syndromes, and implications. New Engl. J. Med., 325, 938-948.
50. Muerhoff, A.S., Griffin, K.J. and Johnson, E.F. (1992) The peroxisome proliferator activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid ω-hydroxylase, by clofibric acid. J. Biol. Chem., 267, 19051-19053.
51. Negrel, R., Grimaldi, P. and Ailhaud, G. (1978) Establishment of preadipocyte clonal cell line from epididymal fat pad of ob/ob mouse that responds to insulin and to lipolytic hormones. Proc. Natl Acad. Sci. USA, 75, 6054-6058.
52. Osmundsen, H., Bremer, J. and Pedersen, J.I. (1991) Metabolic aspects of peroxisomal β-oxidation. Biochim. Biophys. Acta, 1085, 141-158.
53. Osumi, T., Wen, J.K. and Hashimoto, T. (1991) Two cis-acting regulatory elements in the peroxisome proliferator-responsive element enhancer region of rat acyl-CoA oxidase gene. Biochem. Biophys. Res. Commun., 175, 866-871.
54. Palmer, C.N.A., Hsu, M.-H., Muerhoff, A.S., Griffin, K.J. and Johnson, E.F. (1994) Interaction of the Peroxisome Proliferator-Activated Receptor α with the Retinoid X Receptor α unmasks a cryptic peroxisome proliferator response element that overlaps an ARP-1-binding site in the CYP4A6 promoter. J. Biol Chem., 269, 18083-18089.
55. Ramirez, I., Kryski, A.J., Ben-Zeev, O., Schotz, M.C. and Severson, D.L. (1985) Characterization of triacylglycerol hydrolase activities in isolated myocardial cells from rat heart. Biochem. J., 232, 229-236.
56. Randle, P.J., Garland, P.B., Hales, C.N. and Newsholme, E.A. (1961) The glucose-fatty acid cycle:its role in insulin sensitivity and metabolic disturbances of diabetes mellitus. Lancet, i, 785-789.
57. Rodriguez, J.C., Gil-Gomez, G., Hegardt, F.G. and Haro, D. (1994) Peroxisome proliferator activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. J. Biol. Chem., 269, 18767-18772.
58. Sandouk, T., Reda, D. and Hofmann, C. (1993) Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. Am. J. Physiol., 264, C1600-C1608.
59. Schmidt, A., Endo, N., Rutledge, S.J., Vogel, R., Shinar, D. and Rodan, G.A. (1992) Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol. Endocrinol., 6, 1634-1641.
60. Schonfeld, G. (1994) The effects of fibrates on lipoprotein and hemostatic risk factors. Atherosclerosis, 111, 161-174.
61. Schonfeld, G., Patsch, W., Rudel, L.L., Nelson, C., Epstein, M. and Olson, R.E. (1982) Effects of dietary cholesterol and fatty acids on plasma lipoproteins. J. Clin. Invest., 69, 1072-1080.
62. Schoonjans, K., Staels, B., De Vos, P., Szpirer, J., Szpirer, C., Deeb, S., Verhoeven, G. and Auwerx, J. (1993a) Developmental extinction of liver lipoprotein lipase mRNA expression might be regulated by an NF-1 like site. FEBS Lett., 329, 89-95.
63. Schoonjans, K., Staels, B., Grimaldi, P. and Auwerx, J. (1993b) Acyl-CoA synthetase mRNA expression is controlled by fibric-acid derivatives, feeding and liver proliferation. Eur. J. Biochem., 216, 615-622.
64. Schoonjans, K. et al. (1995) Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter. J. Biol. Chem., 270, 19269-19276.
65. Sher, T., Yi, H.F., McBride, W. and Gonzalez, F.J. (1993) cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry, 32, 5598-5604.
66. Sommariva, D., Bonfiglioloi, D., Pogliaghi, I., Zanaboni, L. and Balboni, E. (1983) Effects of procetofen on serum lipids and lipoproteins and on post-heparin lipase activities in type II and in type IV hyperlipoproteinemic patients. Curr. Ther. Res., 34, 907-915.
67. Sparks, R.L., Strauss, E.E., Zygmunt, A.I. and Phelan, T.E. (1991) Antidiabetic AD4743 enhances adipocyte differentiation of 3T3 T mesenchymal stem cells. J. Cell. Phynsiol., 146, 101-109.
68. Staels, B. and Auwerx, J. (1992) Perturbation of developmental gene expression in rat liver by fibric acid derivatives: lipoprotein lipase and alpha-fetoprotein as models. Development, 115, 1035-1043.
69. Staels, B., Vu-Dac, N., Kosykh, V., Saladin, R., Fruchart, J.C., Dallongeville, J. and Auwerx, J. (1995) Fibrates down-regulate apolipoprotein C-III expression independent of induction of peroxisomal acyl co-enzyme A oxidase. J. Clin. Invest., 95, 705-712.
70. Teboul, L., Gaillard, D., Staccini, L., Inadera, H., Amri, E.Z. and Grimaldi, P. (1995) Thiazolidinediones and fatty acids convert myogenic cells into adipose-like cells. J. Biol. Chem., 270, 28183-28137.
71. Tontonoz, P., Hu, E., Graves, R.A., Budavari, A.I. and Spiegelman, B.M. (1994a) mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev., 8, 1224-1234.
72. Tontonoz, P., Hu, E. and Spiegelman, B.M. (1994b) Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell, 79, 1147-1156.
73. Tontonoz, P., Hu, E., Devine, J., Beale, E.G. and Spiegelman, B.M. (1995) PPARγ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol. Cell. Biol., 15, 351-357.
74. Tugwood, J.D., Isseman, I., Anderson, R.G., Bundell, K.R., McPheat, W.L. and Green, S. (1992) The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J., 11, 433-439.
75. Vu-Dac, N., Schoonjans, K., Laine, B., Fruchart, J.C., Auwerx, J. and Staels, B. (1994) Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. J. Biol. Chem., 269, 31012-31018.
76. Vu-Dae, N., Schoonjans, K., Kosykh, V., Dallongeville, J., Fruchart, J.-C., Staels, B. and Auwerx, J. (1995) Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J. Clin. Invest., 96, 741-750.
77. Wang, C.-S., McConathy, W.J., Kloer, H.U. and Alaupovic, P. (1985) Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J. Clin. Invest., 75, 384-390.
78. Weisweiler, P. (1989) Low-dose cholestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia. Metabolism, 38, 271-275.
79. Wu, J.C., Merlino, G. and Fausto, N. (1994) Establishment and characterization of differentiated nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor α. Proc. Natl Acad. Sci. USA, 91, 674-678.
80. Yu, K., Bayona, W., Kallen, C.B., Harding, H.P., Ravera, C.P., McMahon, G., Brown, M. and Lazar, M.A. (1995) Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem., 270, 23975-23983.
81. Zhang, B., Marcus, S.L., Sajjadi, F.G., Alvares, K., Reddy, J.K., Subramani, S., Rachubinski, R.A. and Capone, J.P. (1992) Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase. Proc. Natl Acad. Sci. USA, 89, 7541-7545.
82. Zhang, B. et al. (1996) Down-regulation of the expression of the obese gene by antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice. J. Biol. Chem., 271, 9455-9459.
83. Zhu, Y., Alvares, K., Huang, Q., Rao, M.S. and Reddy, J.K. (1993) Cloning of a new member of the peroxisome proliferator activated receptor gene family from mouse liver. J. Biol. Chem., 268, 26817-26820.